People: Atara Biotherapeutics Inc (ATRA.OQ)

ATRA.OQ on NASDAQ Stock Exchange Global Select Market

25 Sep 2020
Change (% chg)

$0.42 (+3.35%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Newell, Joseph 

Mr. Joseph Newell serves as Chief Operating Officer, Executive Vice President of the Company since February 2020. From April 2017 to February 2020, Mr. Newell served as our EVP and Chief Technical Operations Officer. From July 2015 to April 2017, he was Vice President, North America Manufacturing at Alexion Pharmaceuticals, Inc., a publicly traded biotechnology company. From March 2008 to July 2015, Mr. Newell served various roles within Amgen, Inc., a publicly traded human therapeutics company, including as Executive Director and Plant Manager from August 2012 to September 2014 and Executive Director, Operations Strategic Planning from September 2014 to June 2015. He received a B.S. from California State Polytechnic University – Pomona.

Basic Compensation

Total Annual Compensation, USD 545,208
Restricted Stock Award, USD 1,240,680
Long-Term Incentive Plans, USD --
All Other, USD 933,285
Fiscal Year Total, USD 2,719,170

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --